AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Oryzon Genomics S.A.

$3.31 -$0.05 (-1.49%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$3.31
Day Range
$3.31$3.45
Year Range
$3.25$4.38
Market Cap
271.28M
AVG Volume
3.43K
Trailing/Forward PE
-88.91/-
PEG ratio
0.96
Dividend Yield
-
Next Earnings Date
2026-10-22
Primary Exchange
Other OTCUS
Revenue (EUR)
02.5M5M7.5M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Revenue (EUR) by quarter
PeriodRevenue (EUR)
26 Q28.69M
26 Q10
25 Q40
25 Q30
25 Q24.22M
25 Q10
24 Q47.36M
24 Q30
24 Q24.11M
24 Q10
Net Income (EUR)
-2M-1M01M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Net Income (EUR) by quarter
PeriodNet Income (EUR)
26 Q2-141.87K
26 Q1-1.21M
25 Q4-1.35M
25 Q3337.25K
25 Q2-31.27K
25 Q1-1.7M
24 Q4-1.21M
24 Q3-1.24M
24 Q2116.2K
24 Q1-1.15M
Operating Income (EUR)
-10M-5M05M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Operating Income (EUR) by quarter
PeriodOperating Income (EUR)
26 Q2-1.74M
26 Q1-1.97M
25 Q4-1.98M
25 Q3-5.09M
25 Q2-2.93M
25 Q1-3.47M
24 Q45.36M
24 Q3-2.51M
24 Q2861.26K
24 Q1-3.24M
EBITDA (EUR)
-5M-2.5M02.5M5M7.5M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF EBITDA (EUR) by quarter
PeriodEBITDA (EUR)
26 Q2-1.71M
26 Q1-1.94M
25 Q4-1.95M
25 Q3-1.45M
25 Q2296.28K
25 Q1-3.44M
24 Q45.31M
24 Q3-2.48M
24 Q2896.83K
24 Q1-3.21M
EPS (EUR)
-0.03-0.02-0.0100.0124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF EPS (EUR) by quarter
PeriodEPS (EUR)
26 Q2-0
26 Q1-0.02
25 Q4-0.02
25 Q30
25 Q2-0
25 Q1-0.03
24 Q4-0.02
24 Q3-0.02
24 Q20
24 Q1-0.02
Expenses (EUR)
-2.5M02.5M5M7.5MR&DSG&A24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Expenses (EUR) by quarter
PeriodExpenses (EUR)
26 Q23.71M
26 Q15.74M
25 Q41.94M
25 Q34.34M
25 Q22.36M
25 Q13.47M
24 Q41.6M
24 Q32.51M
24 Q21.61M
24 Q13.24M
Cash & Debt (EUR)
010M20M30M40MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Cash & Debt (EUR) by quarter
PeriodCash & Debt (EUR)
26 Q214.69M
26 Q122.2M
25 Q428.36M
25 Q334.5M
25 Q231.11M
25 Q13.81M
24 Q45.62M
24 Q38.44M
24 Q210.08M
24 Q110.72M
Debt ratios
-50-25025507524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Debt ratios by quarter
PeriodDebt ratios
26 Q21.26
26 Q12.99
25 Q42.51
25 Q3-35.14
25 Q256.3
25 Q126.23
24 Q410.72
24 Q30.99
24 Q21.24
24 Q10.85
Margins
0%25%50%75%100%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q226 Q2
ORYZF Margins by quarter
PeriodMargins
26 Q297.57%
25 Q296.51%
24 Q495.89%
24 Q295.85%
23 Q498.28%
23 Q298.28%
22 Q497.04%
22 Q296.49%
21 Q492.97%
21 Q291.9%
Return on Capital
-3%-2%-1%0%1%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Return on Capital by quarter
PeriodReturn on Capital
26 Q2-0.12%
26 Q1-1.15%
25 Q4-1.28%
25 Q30.32%
25 Q2-0.03%
25 Q1-2.17%
24 Q4-1.39%
24 Q3-1.28%
24 Q20.13%
24 Q1-1.49%
Shares Outstanding
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q277.51M
26 Q177.51M
25 Q477.51M
25 Q375.2M
25 Q277.51M
25 Q164.75M
24 Q464.07M
24 Q363.38M
24 Q262.95M
24 Q161.22M
Book Value Per Share (EUR)
00.511.5224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Book Value Per Share (EUR) by quarter
PeriodBook Value Per Share (EUR)
26 Q21.54
26 Q11.35
25 Q41.36
25 Q31.41
25 Q21.47
25 Q11.21
24 Q41.36
24 Q31.53
24 Q21.37
24 Q11.26
Total Assets (EUR)
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ORYZF Total Assets (EUR) by quarter
PeriodTotal Assets (EUR)
26 Q2140.61M
26 Q1142.24M
25 Q4144.47M
25 Q3145.95M
25 Q2138.35M
25 Q1107.27M
24 Q4108.72M
24 Q3122.66M
24 Q2110.67M
24 Q1107.79M
Price to Sales
0204060med 17.24Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ORYZF Price to Sales by quarter
PeriodPrice to Sales
Sep 2652.25
Sep 2651.7
Aug 2651.84
Aug 2652.84
Aug 2653.35
Aug 2655.61
Jul 2655.76
Jul 2658.95
Jul 2658.6
Jul 2658.72
Jul 2658.62
Jun 2658.72
Jun 2658.32
Jun 2657.79
Jun 2658.98
May 2658.3
May 2658.57
May 2652.75
May 2652.05
May 2652.34
Apr 2652.33
Apr 2652.14
Apr 2652.31
Apr 2653.14
Mar 2618.84
Mar 2618.74
Mar 2618.45
Mar 2618.16
Feb 2619.77
Feb 2619.84
Feb 2619.69
Feb 2619.78
Jan 2619.73
Jan 2618.44
Jan 2618.81
Jan 2618.75
Jan 2618.61
Dec 2519.1
Dec 2519.21
Dec 2519.16
Dec 2519.32
Nov 2519.39
Nov 2519.53
Nov 2520.79
Nov 2520.9
Oct 2520.87
Oct 2520.78
Oct 2520.74
Oct 2520.78
Oct 2520.57
Sep 2516.31
Sep 2515.77
Sep 2515.79
Sep 2515.8
Aug 2515.85
Aug 2515.8
Aug 2515.82
Aug 2515.91
Aug 2515.98
Jul 2515.77
Jul 2515.93
Jul 2515.55
Jul 2515.46
Jun 2515.35
Jun 2515.61
Jun 2515.57
Jun 2514.86
May 2514.91
May 2514.89
May 2515.16
May 2515.05
May 2514.98
Apr 2514.89
Apr 2515.23
Apr 2515.24
Apr 2515.8
Mar 259.9
Mar 259.92
Mar 259.86
Mar 259.91
Feb 255.27
Feb 255.23
Feb 255.22
Feb 255.26
Jan 255.25
Jan 255.18
Jan 255.46
Jan 255.48
Jan 255.44
Dec 245.35
Dec 245.34
Dec 245.53
Dec 245.27
Nov 246.93
Nov 246.37
Nov 246.3
Nov 246.19
Nov 246.12
Oct 246.15
Oct 246.11
EV/EBITDA
0200400600800med 53.69Feb 24Sep 24Dec 24Mar 25Jun 25Sep 25Mar 26
ORYZF EV/EBITDA by quarter
PeriodEV/EBITDA
Mar 26267.62
Mar 26266.02
Mar 26261.3
Mar 26256.68
Feb 26282.51
Feb 26283.64
Feb 26281.27
Feb 26282.74
Jan 26281.8
Jan 26261.2
Jan 26267.05
Jan 26266.11
Jan 26263.93
Sep 25667.16
Sep 25645.94
Sep 25646.74
Sep 25647.18
Aug 25648.93
Aug 25646.96
Aug 25647.91
Aug 25651.44
Aug 25654.36
Jul 25646.13
Jul 25652.33
Jul 25637.48
Jul 25633.89
Jun 25348.54
Jun 25354.17
Jun 25353.33
Jun 25337.59
May 25338.85
May 25338.33
May 25344.33
May 25341.83
May 25340.34
Apr 25338.33
Apr 25345.83
Apr 25345.98
Apr 25358.33
Mar 2542.14
Mar 2542.22
Mar 2541.94
Mar 2542.17
Feb 2522.9
Feb 2522.72
Feb 2522.66
Feb 2522.86
Jan 2522.8
Jan 2522.52
Jan 2523.69
Jan 2523.74
Jan 2523.6
Dec 2437.93
Dec 2437.91
Dec 2439.23
Dec 2437.43
Nov 2448.78
Nov 2444.97
Nov 2444.46
Nov 2443.75
Nov 2443.27
Oct 2443.44
Oct 2443.17
Oct 2442.9
Oct 2442.76
Sep 2424.59
Sep 2424.59
Sep 2424.78
Sep 2424.75
Aug 2424.83
Aug 2418.15
Aug 2418.41
Aug 2418.59
Aug 2418.59
Jul 2418.69
Apr 2432.29
Mar 2458
Feb 2453.39
Feb 2453.5
Feb 2453.7
Feb 2453.67
Feb 2448.46
Jan 2448.18
Jan 2448
Jan 2447.86
Nov 2373.43
Sep 2379.26
May 2390.65
Price to Book
0.511.522.5med 2.07Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ORYZF Price to Book by quarter
PeriodPrice to Book
Sep 262.11
Sep 262.08
Aug 262.09
Aug 262.13
Aug 262.15
Aug 262.24
Jul 262.25
Jul 262.38
Jul 262.36
Jul 262.37
Jul 262.36
Jun 262.35
Jun 262.33
Jun 262.31
Jun 262.36
May 262.33
May 262.34
May 262.11
May 262.08
May 262.1
Apr 262.09
Apr 262.09
Apr 262.09
Apr 262.13
Mar 262.06
Mar 262.05
Mar 262.02
Mar 261.99
Feb 262.16
Feb 262.17
Feb 262.16
Feb 262.17
Jan 262.16
Jan 262.02
Jan 262.06
Jan 262.05
Jan 262.04
Dec 251.94
Dec 251.95
Dec 251.94
Dec 251.96
Nov 251.97
Nov 251.98
Nov 252.11
Nov 252.12
Oct 252.12
Oct 252.11
Oct 252.1
Oct 252.11
Oct 252.09
Sep 252.39
Sep 252.31
Sep 252.32
Sep 252.32
Aug 252.33
Aug 252.32
Aug 252.32
Aug 252.33
Aug 252.35
Jul 252.31
Jul 252.34
Jul 252.28
Jul 252.27
Jun 252.02
Jun 252.06
Jun 252.05
Jun 251.96
May 251.96
May 251.96
May 252
May 251.98
May 251.97
Apr 251.96
Apr 252.01
Apr 252.01
Apr 252.08
Mar 251.87
Mar 251.87
Mar 251.86
Mar 251.87
Feb 251
Feb 250.99
Feb 250.99
Feb 250.99
Jan 250.99
Jan 250.98
Jan 251.03
Jan 251.03
Jan 251.03
Dec 241.13
Dec 241.13
Dec 241.17
Dec 241.12
Nov 241.46
Nov 241.35
Nov 241.33
Nov 241.31
Nov 241.3
Oct 241.3
Oct 241.29
Oryzon Genomics S.A.
ORYZF
Stockpicker

Video analysis: ORYZF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.